Many individuals continue to use tobacco after a cancer diagnosis, and there are gaps in resources specifically addressing cessation among cancer survivors. The Comprehensive Cancer Control National Partnership has designated tobacco cessation services for cancer survivors to be one of their three main priority issues. Dr. Jamie Ostroff, Director of Memorial Sloan Kettering Cancer Center's Tobacco Treatment Program, will discuss the practice-related aspects of this issue including:
- Best practices in promoting tobacco cessation among cancer patients and survivors.
- Current gaps in promoting tobacco cessation among cancer patients and survivors.
- Integration of tobacco cessation services across models of oncology care.
- Resources available for achieving tobacco cessation among cancer patients and survivors.
- Opportunities and strategies to increase implementation of tobacco cessation best practices and address gaps.
This webinar is second in a three-part series hosted with National Partnership organizations, discussing tobacco cessation services for cancer survivors from the perspectives of research, practice, and coalition examples. Watch an archived recording of the first webinar in the series from National Cancer Institute's Research to Reality, "Tobacco Control and Cancer Survivorship: From Science to Strategies."
Jamie S. Ostroff, PhD
Psychologist; Chief, Behavioral Sciences Service; Director, Tobacco Treatment Program; Memorial Sloan Kettering Cancer Center
I am a clinical health psychologist with expertise in helping patients and their families cope with the challenges of cancer diagnosis, treatment, and survivorship. I have a strong interest in working with patients who have been diagnosed with tobacco-related cancers, and I serve as psychological liaison to the Thoracic Service and to the Head and Neck Disease Management Team. I am the Director of Memorial Sloan Kettering’s Tobacco Treatment Program and work with a team of colleagues dedicated to promoting smoking cessation among cancer patients, their families, and individuals at risk for cancer and other chronic medical conditions.